Location San Diego, California, United States Regions Greater San Diego Area, West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Han Cao founded BioNanomatrix in 2003 as a spin out of the Princeton University laboratories where he was working on a multi-million dollar project funded by the U.S. Defense Advanced Research Projects Agency (DARPA). Dr. Cao is the key co-inventor of the company's core single-molecule nanoscale whole genome analysis technology. Prior to that,
he was a postdoctoral fellow working on stem cell and DNA repair system at Institute for Human Gene Therapy of University of Pennsylvania Medical Center. His diverse experience includes molecular biology, microarray and genomics technology development, single molecule analysis as well as micro and nanofluidics design and fabrication. Dr. Cao leads multiple federal government funded projects at BioNanomatrix and served on many grant review panels. He oversees the scientific and technical direction of future technology and product development at BioNanomatrix. Dr. Cao received a B.S. degree from the University of Science and Technology of China and a Ph.D. in molecular biology from the University of Delaware.
